Chengdu Wesley: A Top Player in China’s Hemodialysis Machine Sector
[China Medical Technology News] Amid the accelerated domestic substitution of hemodialysis machines in China, Chengdu Wesley Biotechnology Co., Ltd. (hereinafter referred to as “Chengdu Wesley”) has successfully emerged as a leading player in the industry, relying on continuous technological innovation, full industrial chain layout advantages and stable market performance. The latest industry data shows that Chengdu Wesley ranks top 3 in China’s blood purification equipment market, with a significant growth in market share, becoming an important force driving the high-quality development of domestic hemodialysis machines.
As a national high-tech enterprise in Sichuan Province focusing on the hemodialysis machine field, Chengdu Wesley has deepened its presence in the industry for many years, building a professional product matrix centered on hemodialysis machines and forming a complete closed loop of “R&D-production-sales-service”. This full-chain layout not only enhances the core competitiveness of its hemodialysis machine products but also ensures stable supply and efficient services for medical institutions at all levels, laying a solid foundation for the improvement of its market position.
Technological innovation is the core driving force for Chengdu Wesley to stand out in the hemodialysis machine industry. The company has accumulated more than 100 patents, achieving continuous breakthroughs in the core technologies of hemodialysis machines, especially forming differentiated advantages in precise control, safety protection and intelligent upgrading of hemodialysis machines. Relying on independent R&D capabilities, its hemodialysis machine products are optimized and designed for different application scenarios. Core models such as W-T2008-B and W-T6008S have been repeatedly awarded government procurement projects in China, gaining wide recognition from medical institutions at all levels due to their stable operation performance, precise dialysis parameter control and reliable safety guarantee system. Compared with imported similar products, the company’s hemodialysis machine has a higher cost-performance advantage, effectively reducing the procurement pressure of medical institutions and helping hemodialysis services sink to the grassroots level.
Stable market performance and revenue growth confirm Chengdu Wesley’s industrial competitiveness. Relying on core technological breakthroughs and product advantages, the company’s revenue has maintained steady growth, reaching 163 million yuan from January to November 2025, a year-on-year increase of 71.3%, showing a strong growth momentum. In the domestic market, its hemodialysis machine has been widely used in medical institutions in many provinces such as Hunan and Sichuan. Through participating in government procurement, connecting with private medical care and other diversified channels, it continues to expand market coverage; in the international market, the hemodialysis machine has been sold to more than 10 countries and regions overseas, gaining recognition from overseas customers for its high cost-performance ratio and scenario adaptability.
Post time: Jan-13-2026
